Showing 41-50 of 198 results for "".
Case Report: Treatment of Refractory Pemphigus Foliaceus with Rituximab; Financial Matters; AAD; ASDS Resources
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-treatment-of-refractory-pemphigus-foliaceus-with-rituximab-financial-matters-aad-asds-resources/21033/Multiple Eruptive Myxoid Dermatofibromas in Patient With History of HIV
https://practicaldermatology.com/programs/practical-dermatology/multiple-eruptive-myxoid-dermatofibromas-in-patient-with-history-of-hiv/24216/Multiple eruptive dermatofibromas, a rare presentation of dermatofibroma, has been associated with altered immunity such as HIV/AIDS.The State of Prevention in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/the-state-of-prevention-in-atopic-dermatitis/23183/Antioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.Vitiligo: Oral and Topical JAKs Show Promise
https://practicaldermatology.com/topics/pigmentary-disorders/vitiligo-oral-and-topical-jaks-show-promise/23316/Early studies offer some hope for emerging therapies for repigmentation.Statins and Skin Cancer: The Latest Data
https://practicaldermatology.com/topics/skin-cancer-photoprotection/statins-and-skin-cancer-the-latest-data/20426/A look at another commonly used drug and its potential association with skin cancer risks.Comorbidities in Immune-mediated Skin Disorders: What’s Coming
https://practicaldermatology.com/issues/january-february-2025/comorbidities-in-immune-mediated-skin-disorders-whats-coming/32968/Comorbidities in immune-mediated skin disorders (IMSDs) occur frequently and have a significant impact on disease severity, treatment, prognosis, and quality of life.Basal Cell Carcinoma in Skin of Color: A Case Series
https://practicaldermatology.com/topics/skin-cancer-photoprotection/basal-cell-carcinoma-in-skin-of-color-a-case-series/23814/BCC is not common in patients with skin of color; it tends to have a delayed diagnosis and can have a more serious disease course.Currents: Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/currents-eczema/23371/Assessing Clinical Options for Moderately Dysplastic Nevi Excised with Positive Margins
https://practicaldermatology.com/topics/skin-cancer-photoprotection/assessing-clinical-options-for-moderately-dysplastic-nevi-excised-with-positive-margins/20322/The latest data support the decision to monitor patients rather than re-excise when the pathology report confirms moderate dysplasia with positive margins.